Saltar al contenido
Merck

Retinoic acid signalling during development.

Development (Cambridge, England) (2012-02-10)
Muriel Rhinn, Pascal Dollé
RESUMEN

Retinoic acid (RA) is a vitamin A-derived, non-peptidic, small lipophilic molecule that acts as ligand for nuclear RA receptors (RARs), converting them from transcriptional repressors to activators. The distribution and levels of RA in embryonic tissues are tightly controlled by regulated synthesis through the action of specific retinol and retinaldehyde dehydrogenases and by degradation via specific cytochrome P450s (CYP26s). Recent studies indicate that RA action involves an interplay between diffusion (morphogen-like) gradients and the establishment of signalling boundaries due to RA metabolism, thereby allowing RA to finely control the differentiation and patterning of various stem/progenitor cell populations. Here, we provide an overview of the RA biosynthesis, degradation and signalling pathways and review the main functions of this molecule during embryogenesis.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Ácido retinoico, ≥98% (HPLC), powder
Supelco
Ácido retinoico, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Ácido retinoico, United States Pharmacopeia (USP) Reference Standard
Ácido retinoico, European Pharmacopoeia (EP) Reference Standard